Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

UArizona researcher finds a unique approach to tackle both Alzheimer’s disease and diabetes

Study reveals new approach for treating diabetic foot ulcers

Study reveals new approach for treating diabetic foot ulcers

Investments in life sciences can be appealing to many investors as vaccines are rolled out

Investments in life sciences can be appealing to many investors as vaccines are rolled out

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

Insights into elusive protein complex can help find novel treatments for chromosomal disorders

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

INTEGRA’s VOYAGER adjustable tip spacing pipettes streamline the production of venom-based screening assays

Axol Bioscience and Censo Biotechnologies Announce Merger

Axol Bioscience and Censo Biotechnologies Announce Merger

Newly identified drugs can help treat oral and esophageal carcinomas

Newly identified drugs can help treat oral and esophageal carcinomas

Study could lead to the development of novel treatments for drug-resistant cancers

Study could lead to the development of novel treatments for drug-resistant cancers

New machine learning technique could quicken the pace of drug discovery

New machine learning technique could quicken the pace of drug discovery

48Hour Discovery and Merck join hands to accelerate drug development

48Hour Discovery and Merck join hands to accelerate drug development

Cats with chronic kidney disease may help inform treatment for humans in future

Cats with chronic kidney disease may help inform treatment for humans in future

New book provides general introduction about COVID-19, history, and diagnosis

New book provides general introduction about COVID-19, history, and diagnosis

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Study addresses glycosylation concerns in SARS-CoV-2 vaccine design

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Project Helios launched to unlock new approaches in small molecule drug discovery

Project Helios launched to unlock new approaches in small molecule drug discovery

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Human cerebral organoid model to screen drugs for treatment of Creutzfeldt-Jakob disease

Scientists target critical interface that is key for cancer cell survival

Scientists target critical interface that is key for cancer cell survival

Parkinson’s UK, University of Sheffield to develop new Parkinson’s drug

Parkinson’s UK, University of Sheffield to develop new Parkinson’s drug

Researchers identify human BCAS3 and C16orf70 as novel autophagic proteins

Researchers identify human BCAS3 and C16orf70 as novel autophagic proteins

Study demonstrates the impact of 'reverse antibiotic' on gram-negative bacteria

Study demonstrates the impact of 'reverse antibiotic' on gram-negative bacteria

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.